ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 479,40
-0,68%
Dow Jones
39 118,86
-0,12%
DAX
18 235,45
0,17%
Brent Oil
84,85
0,00%
Bitcoin
60 654,15
0,57%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Barr Pharmaceuticals (BRL)

  7. Barr Pharmaceuticals (BRL) Actualités

BRL

Barr (BRL)

Barr Pharmaceuticals
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:BRL
DateHeureSourceTitreSymboleSociété
19/03/201312h30ZacksIs It Time to Buy the Brazil ETF (EWZ)? - ETF News And CommentaryNYSE:BRLBarr Pharmaceuticals
03/09/201010h05DPA AFX NachrichtenAKTIE IM FOKUS: Bayer leicht im Plus - Dämpfer im Yasmin-Streit in den USANYSE:BRLBarr Pharmaceuticals
16/06/201008h15DPA AFX NachrichtenAktien Frankfurt Ausblick: Freundlich erwartet – Rückenwind aus den USANYSE:BRLBarr Pharmaceuticals
22/12/200823h00PR Newswire (US)Warner Chilcott and Barr Announce Settlement of Femcon(R) Fe Patent ChallengeNYSE:BRLBarr Pharmaceuticals
22/12/200821h23Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NYSE:BRLBarr Pharmaceuticals
19/12/200821h00Business WireU.S. Federal Trade Commission Clears Teva’s Acquisition of BarrNYSE:BRLBarr Pharmaceuticals
19/12/200821h00PR Newswire (US)U.S. Federal Trade Commission Clears Teva's Acquisition of BarrNYSE:BRLBarr Pharmaceuticals
19/12/200820h19PR Newswire (US)Teva and Barr Receive European Commission Approval For AcquisitionNYSE:BRLBarr Pharmaceuticals
19/12/200819h25Business WireTeva and Barr Receive European Commission Approval for AcquisitionNYSE:BRLBarr Pharmaceuticals
19/12/200819h13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:BRLBarr Pharmaceuticals
19/12/200800h09PR Newswire (US)Standard & Poor's Announces Update to the U.S. Market Cap Guidelines and Changes to U.S. IndicesNYSE:BRLBarr Pharmaceuticals
11/12/200815h53PR Newswire (US)Barr's BLA for Adenovirus Type 4 and 7 Live Oral Vaccines Accepted for Filing by FDANYSE:BRLBarr Pharmaceuticals
08/12/200819h15Business WireTeva Draws on $1.75 Billion Bridge Financing in Connection with Pending Barr AcquisitionNYSE:BRLBarr Pharmaceuticals
01/12/200815h06PR Newswire (US)FDA Approves Duramed's Synthetic Conjugated Estrogens-A Vaginal CreamNYSE:BRLBarr Pharmaceuticals
26/11/200818h20PR Newswire (US)Barr Confirms Patent Challenge of Amrix(R) Extended-Release Capsules, 15mg & 30mgNYSE:BRL
21/11/200822h44Edgar (US Regulatory)Current report filing (8-K)NYSE:BRLBarr Pharmaceuticals
21/11/200820h00PR Newswire (US)Barr Shareholders Approve Pending Teva AcquisitionNYSE:BRLBarr Pharmaceuticals
20/11/200823h30Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (DEFA14A)NYSE:BRLBarr Pharmaceuticals
19/11/200814h00PR Newswire (US)Perrigo Acknowledges Settlement of NASACORT(R) AQ Nasal Spray Patent LitigationNYSE:BRLBarr Pharmaceuticals
19/11/200807h30PR Newswire (US)Barr Announces Agreements on Nasacort(R) AQ, Allegra(R) D-12 and Allegra(R) Patent ChallengesNYSE:BRLBarr Pharmaceuticals
06/11/200821h03Edgar (US Regulatory)Quarterly Report (10-Q)NYSE:BRLBarr Pharmaceuticals
06/11/200813h30PR Newswire (US)Barr Reports Third Quarter 2008 GAAP Earnings of $0.28 Per Share; Adjusted Earnings of $0.83 Per ShareNYSE:BRLBarr Pharmaceuticals
03/11/200819h41PR Newswire (US)Barr Announces Approval of Generic Camptosar(R) Injection, 20 mg/mLNYSE:BRLBarr Pharmaceuticals
27/10/200822h30Business WireTeva and Barr Provide Update on AcquisitionNYSE:BRLBarr Pharmaceuticals
27/10/200814h12PR Newswire (US)FDA Approves Duramed's LoSEASONIQUE(R) Oral ContraceptiveNYSE:BRLBarr Pharmaceuticals
24/10/200818h46PR Newswire (US)Barr Confirms Patent Challenge of Oxytrol(R)NYSE:BRLBarr Pharmaceuticals
21/10/200819h23PR Newswire (US)Barr Confirms Patent Challenge of Opana(R) ER Extended-Release Tablets, 5 mg, 10 mg, 20 mg and 40 mgNYSE:BRLBarr Pharmaceuticals
17/10/200822h03PR Newswire (US)Barr Revises Timing of Its Earnings Conference Call to Discuss the Results for the Third Quarter of Calendar 2008 to 9:00 AM EasNYSE:BRLBarr Pharmaceuticals
16/10/200817h28PR Newswire (US)Barr Says Court of Appeals Upholds 2005 District Court Decision on 1997 Cipro(R) SettlementNYSE:BRLBarr Pharmaceuticals
16/10/200816h01PR Newswire (US)Barr Announces Date for Special Shareholder MeetingNYSE:BRLBarr Pharmaceuticals
 Showing the most relevant articles for your search:NYSE:BRL

Dernières Valeurs Consultées

EU
F314S
F314S
LSE
67HF
Bancobil 4.75%
BIT
US37
Amundi US Treasury Bond ...
BIT
UC7Z1H
Unicredit Bank
TG
7XP
Organon &
USOTC
BTRYF
Waratah Minerals (PK)
BIT
F18308
Vontobel Financial Produ...
USOTC
MCQEF
Macquarie (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés